EMA’s building approval process in Amsterdam initiated
New permanent building to be completed by 15 November 2019...
List view / Grid view
News
Tempol provides a potential treatment for Chuvash polycythemia
A study in mice suggests that experimental drug may be effective against mountain sickness and other polycythemias...
Charles River Laboratories announces new tumour model compendium
The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies.
New directions found in understanding, fighting glaucoma
Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma.
GAPSA reveals new HIV targets
Researchers have developed the first-ever high-throughput, genome-scale imaging-based approach to investigate protein stability...
Neural stem cell treatment may offer relief for MS
Scientists have shown that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by MS...
Scientists discover critical molecular biomarkers of preeclampsia
Small non-coding RNAs may be used to devise a diagnostic blood test for pregnant women...
New analytical method provides an insight into additional chromosomes
A new technique promises to identify additional chromosomes involved in carcinogenesis.
Five genetic changes linked to pancreatic cancer risk
Researchers have discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer...
HIC1 protein may protect against intestinal disease
Scientists find molecular link between Vitamin A derivative and mouse intestinal health...
Autoimmune disease research community gets boost from AMP RA/SLE study results
Data from the Phase I study of collaborative industry partnership AMP are now available, meaning scientists can benefit from access to important research about Rheumatoid Arthritis and Systemic Lupus Erythematosus.
CRISPR/Cas9 variant holds promise for Huntington’s disease treatment
Improvements to gene-editing techniques hold promise for inactivating the defective gene responsible for this as-yet incurable disease...
Antibodies provide potential targets for RSV vaccine development
Scientists have found and characterised the activity of four antibodies produced by the human immune system that targets an important protein found in the respiratory syncytial virus...
Researchers develop synthetic bioluminescence to view body’s cells externally
Researchers in Japan have ramped up nature’s wonder that is bioluminescence to enable deep tissue cells to be seen from outside the body.
Mouse study demonstrates that gut microbes protect against sepsis
A recent study at the University of Pennsylvania has identified that introducing particular microflora to the blood of mice increases immunoglobin A (IgA) levels, which appears to aid survival against sepsis.